Study ID: 109035 Clinical Study ID: 109035 Study Title: A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy and Safety of GSK163090 in Subjects With Major Depressive Disorder Patient Level Data: Study Listed on Identifier: NCT00896363 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: GSK163090 1 mg, GSK163090 Placebo, GSK163090 3 mg Trade Name: Study Indication: Depressive Disorder

Versions (1) ▾
  1. 11/17/19
Copyright Holder:
Uploaded on:

November 17, 2019

No DOI assigned. To request one pleaselog in.
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Efficacy and Safety of GSK163090 in Subjects with Major Depressive Disorder; NCT00896363

Psychiatric History

  1. StudyEvent: ODM
    1. Psychiatric History
Psychiatric History
Dysthymic Disorder
Hypomanic Episode
Manic Episode
Panic Disorder
Social Phobia/Social Anxiety Disorder
Obsessive Compulsive Disorder
Generalized Anxiety Disorder
Post-Traumatic Stress Disorder
Alcohol Abuse
Alcohol Dependence
Substance Abuse (Non-alcohol)
Substance Dependence (Non-alcohol)
Nicotine Dependence
Anorexia Nervosa
Bulimia Nervosa
Psychotic Disorders
Schizophrenia Disorder
Schizoaffective Disorder
Bipolar I Disorder
Bipolar II Disorder
Cyclothymic Disorder
Schizoid Personality Disorder
Paranoid Personality Disorder
Anti-Social Personality Disorder
Attention Deficit/Hyperactivity Disorder
Sleep Disorder
Borderline Personality Disorder
Suicidal Ideation
Other Psychiatric Disorder
Start / End dates